Taiwan FDA registration ed093fbe35d698cbec2686041c681e3f
EliA APS Positive controls
TW: 宜立亞抗磷脂症候群陽性品管液
Taiwan·Risk Class 2·MD·PHADIA AB·Registered May 22, 2015 – May 22, 2025ExpiredRegistration details
- Analysis ID
- ed093fbe35d698cbec2686041c681e3f
- License Form
- Ministry of Health Medical Device Import No. 027339
- Customs Code
- DHA05602733900
Company information
- Manufacturer
- PHADIA AB
- Manufacturer Country
- Sweden
- Authorized Representative
- PHADIA TAIWAN INC.
Product details
- Intended Use
- This product is used to monitor the performance of cardiolipin and β2-glycoprotein I antibodies during in vitro assays on the Fadia 100 and Fadia 250 instruments.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1660 Quality Control Materials (Analytical and Non-Analytical)
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- May 22, 2015
- Expiry Date
- May 22, 2025
About this record
Access comprehensive regulatory information for EliA APS Positive controls in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number ed093fbe35d698cbec2686041c681e3f and manufactured by PHADIA AB. The authorized representative in Taiwan is PHADIA TAIWAN INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices